HEATHER MARCUM: Open Payments
NPI 1467872283 · DURANT, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 39 payments from 11 companies in 2025. Trend: 2023 $335 · 2024 $473 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $146 |
| Vanda Pharmaceuticals Inc. | 11 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Novo Nordisk Inc | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: VRAYLAR, FANAPT, CAPLYTA, REXULTI, MOUNJARO, Auvelity, FARXIGA, Ozempic.
Industry payments across OK — which companies pay providers there.
